Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00435292 · ClinicalTrials.gov registry record · NA
Study of Flavocoxid (Limbrel) vs Naproxen in Subjects With Mod-Severe Osteoarthritis of the Knee
A NA study of Osteoarthritis, sponsored by Primus Pharmaceuticals.
- Completed
- Registry status
- NA
- Development phase
- 350
- Enrollment target
- 1
- Study location
NCT00435292: Completed NA study of Osteoarthritis, sponsored by Primus Pharmaceuticals.
NCT00435292 is a NA study of Osteoarthritis that has completed, run by Primus Pharmaceuticals. The registered enrollment target is 350 participants, below the 815-participant average among 135 other Osteoarthritis trials with a reported enrollment target (57% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00435292, a NA study of Osteoarthritis, has completed, sponsored by Primus Pharmaceuticals.
- COMPLETED
- Registry status
- NA
- Development phase
- 350 participants
- Enrollment target
- 1
- Study location
Study Summary
Randomized, double-blind, placebo controlled parallel group, multi center study in subjects with moderate-severe osteoarthritis.
Conditions Studied
Interventions
- DRUG Naproxen
- DIETARY_SUPPLEMENT flavocoxid 250 mg
- DIETARY_SUPPLEMENT flavocoxid 500 mg
Study Locations (1)
Arizona
- Primus Pharmaceuticals, Inc - Scottsdale
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 350 participants |
| Start Date | 2006-04 |
| Est. Completion | 2007-12 |
| Phase | NA |
What the finished NCT00435292 record still lists
NCT00435292 is an interventional study that assigns participants to a tested intervention. The registered 350 participants enrollment target is mid-sized for trials with a published cap, below the 815-participant average among 135 other Osteoarthritis trials with a reported enrollment target (57% lower).
The record links to 1 condition, with Osteoarthritis appearing as the primary indexed condition, and to 3 interventions - of which Naproxen is the first listed.
NCT00435292 reports a single indexed study location in Arizona.
Frequently Asked Questions
What is clinical trial NCT00435292 about?
NCT00435292 is a clinical study titled "Study of Flavocoxid (Limbrel) vs Naproxen in Subjects With Mod-Severe Osteoarthritis of the Knee". Randomized, double-blind, placebo controlled parallel group, multi center study in subjects with moderate-severe osteoarthritis.
What is the current status of trial NCT00435292?
This trial is currently completed. It is a NA study. The enrollment target is 350 participants. The study started on 2006-04. Estimated completion is 2007-12.
What conditions does trial NCT00435292 study?
This clinical trial studies the following conditions: Osteoarthritis.
What interventions are being tested in trial NCT00435292?
The interventions under investigation include: Naproxen (DRUG), flavocoxid 250 mg (DIETARY_SUPPLEMENT), flavocoxid 500 mg (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT00435292?
This trial is sponsored by Primus Pharmaceuticals, which has 15 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00435292 being conducted?
This trial has 1 study location across Arizona. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Osteoarthritis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00435292's enrollment target sits among peer trials
350 37th of 135 higher than 99 of 135 other Osteoarthritis trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Osteoarthritis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
EMPHASYS Cup Positioning in THA With Non-Invasive Navigation (Velys Hip Navigation (VHN))
RECRUITING · NA
-
The PROACTIVE Study for Black Elders
RECRUITING · NA
-
Trans-arterial Embolization for the Treatment of Facet Pain Due to Facet Arthropathy
RECRUITING · NA
-
Dose Response of Exercise for Arthritis Management
RECRUITING · NA
-
Conversations in Health Literacy Using AI Technology for Osteoarthritis Patients
RECRUITING · NA
-
Activating SilverSneakers Benefits for Seniors With Osteoarthritis
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00900575 · 350 participants · NA
Cervical Cancer Detection Using Optical Spectroscopy
- NCT01627821 · 350 participants · NA
Evaluation of the Jarvik 2000 Left Ventricular Assist System With Post-Auricular Connector--Destination Therapy Study
- NCT02357654 · 350 participants · Phase 4
GnRH for Luteal Support in IVF/ICSI/FET Cycles
- NCT03997370 · 350 participants · Phase 1
Evaluation of Dosing Procedures of Chemotherapy Treatment (Carboplatin) With the Contrast Agent Iohexol
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia